Stocks to Track: Sarepta Therapeutics Inc (NASDAQ:SRPT), ASML Holding NV (ADR) (NASDAQ:ASML)
Trading the news is a technique to trade equities, currencies and other financial instruments on the financial markets. Trading news releases can be a noteworthy tool for financial shareholders. Economic news reports often drive strong short-term moves in the markets, which may create trading opportunities for traders. Declarations about corporate profits, a change in administration, rumors of a merger, are events that can cause a company’s share price to move wildly up or down. Interest rates, unemployment and export rates, or the central bank’s policy shifts, can cause a deep change of an exchange rate.
Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) gained 0.56% to $34.08 on Wednesday, after a biopharmaceutical company stated a loss of $63 million in its second quarter. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.15.
The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share. The biopharmaceutical company posted revenue of $35 million in the period, which beat Street forecasts. Seven analysts surveyed by Zacks predictable $21.8 million.
The stock settled at $34.08 per share, after floating in a range of $32.80 to $34.53. The stock moved on low volume, traded at a volume of 43,871 shares, as compared to its average daily volume of 1.33 million shares. The market capitalization billion for the company is reported at $1.82B.
ASML Holding NV (ADR) (NASDAQ:ASML) opened at $148.62. It reached an intraday trading high of $147.96 and closed at $150.63.
The stock price inclined 7.38 points or 5.15% at the market. This upward move comes after a holding company beats 2Q profit forecasts. The company stated second-quarter earnings of $466.3 million. On a per-share basis, the Veldhoven, Netherlands-based company said it had profit of $1.08.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.06 per share. The equipment supplier to semiconductor makers posted revenue of $2.1 billion in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks predictable $2.21 billion.
The total volume traded for the day is 2.52 million, as compared to its average daily volume of 935,228 shares. The current EPS for the company has been recorded at $4.65 and the beta value recorded by the company stands at 1.07 points.